Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method
1 other identifier
interventional
207
1 country
7
Brief Summary
The aim of this study are to evaluate the feasibility of needle knife fistulotomy (NKF) as an initial procedure for biliary access in patients with biliary disease who are at increased risk for post-endoscopic retrograde endoscopic retrograde cholangiopancreatography (PEP) and to assess the incidence rate of complications including PEP between NKF and conventional cannulation methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2016
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 24, 2016
CompletedFirst Posted
Study publicly available on registry
September 27, 2016
CompletedStudy Start
First participant enrolled
October 4, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 28, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 28, 2017
CompletedJanuary 30, 2019
January 1, 2019
1.2 years
September 24, 2016
January 29, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence rate of post-endoscopic retrograde cholangiopancreatography
1 week
Secondary Outcomes (3)
Incidence rate of complications including bleeding, perforation and infection
1 week
Success rate of cannulation
1 day
Success rate of stone removal
1 day
Study Arms (2)
Needle knife fistulotomy
EXPERIMENTALDevice: Needle knife fistulotomy Disease: Common bile duct stone, Malignant biliary stricture, Benign biliary stricture, Benign pancreatic disease, biliary sphincter of Oddi dysfunction Indication: High risk of post-endoscopic retrograde cholangiopancreatography pancreatitis \- Intervention: canulation of ampulla of Vater Intervention: canulation of ampulla of Vater
conventional cannulation
ACTIVE COMPARATORDevice: conventional canulation catheter Disease: Common bile duct stone, Malignant biliary stricture, Benign biliary stricture, Benign pancreatic disease, biliary sphincter of Oddi dysfunction Indication: High risk of post-endoscopic retrograde cholangiopancreatography pancreatitis \- Intervention: canulation of ampulla of Vater Intervention: canulation of ampulla of Vater
Interventions
Cannulation of ampulla of Vater is a procedure that a guide-wire is passed through ampulla using interventional devices
Eligibility Criteria
You may qualify if:
- Patient who submitted a written informed consent for the this trial, and 18 \~ 90 years old
- Patient who have naïve ampulla (no previous procedure was performed at ampulla)
- Patient who is suspected to have biliary obstruction or biliary disease
- Patient who is needed to have endoscopic retrograde cholangiopancreatography for treatment of biliary obstruction
- Patient who have risks of post-endoscopic retrograde cholangiopancreatography pancreatitis among bellows (at least one more);
- suspected biliary sphincter of Oddi dysfunction
- young age (18\~50 years)
- female
- normal common bile duct diameter (≤9mm)
- normal serum bilirubin level
- Obesity (body mass index \> 30)
- Past history of acute pancreatitis
You may not qualify if:
- Patient who is below 18 year old
- Patient who is pregnant
- Patient with mental retardation
- Patient is sensitive to contrast agents
- Patient who received sphincterotomy or pancreatobiliary operation previously
- Patient who have ampulla of Vater cancer
- Patient who have difficulty for approach to ampulla due to abdominal surgery including stomach cancer with Billroth II anastomosis
- Patient who have pancreatic diseases as bellow (at least one more);
- Patient who have acute pancreatitis within 30days before enrollment
- Patient who have idiopathic acute recurrent pancreatitis
- Patient who have pancreatic divisum
- Patient who have obstructive chronic pancreatitis
- Patient who pancreatic cancer
- Patients who have improper ampulla shape as bellows;
- Small ampulla (ampulla without oral protrusion)
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
CHA Bundang Medical Center
Seongnam, Bundang-gu, 13496, South Korea
Gangnam Severance Hospital
Seoul, Gangnam-gu, 06229, South Korea
Dongtan Sacred Heart Hospital
Hwaseong-si, Gyeonggi-do, 18450, South Korea
In Ha University Hospital
Incheon, Jung-gu, 22332, South Korea
Soon Chun Hyang University Hospital, Cheonan
Cheonan, Namdong-gu, 31151, South Korea
Gachon University Gil Medical Center
Incheon, Namdong-gu, 21565, South Korea
Pusan National University Hospital
Busan, Seo-gu, 49241, South Korea
Related Publications (1)
Jang SI, Kim DU, Cho JH, Jeong S, Park JS, Lee DH, Kwon CI, Koh DH, Park SW, Lee TH, Lee HS. Primary Needle-Knife Fistulotomy Versus Conventional Cannulation Method in a High-Risk Cohort of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Am J Gastroenterol. 2020 Apr;115(4):616-624. doi: 10.14309/ajg.0000000000000480.
PMID: 31913191DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
September 24, 2016
First Posted
September 27, 2016
Study Start
October 4, 2016
Primary Completion
November 28, 2017
Study Completion
November 28, 2017
Last Updated
January 30, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share